Abstracts

GROWTH DEFICITS ARE ASSOCIATED WITH AIRFLOW OBSTRUCTION IN PERINATALLY ACQUIRED HIV

Chronic lung disease (CLD) is an emerging comorbidity among youth living with perinatally-acquired HIV (YPHIV) globally. Obstructive CLD, particularly with irreversible airflow obstruction (AFO) such as with obliterative bronchiolitis and poorly controlled asthma, may be an important subtype. We hypothesized that AFO, with and without reversibility, is common in low/middle-income and high-income settings but that…

GLOBAL TRENDS IN PEDIATRIC ON-TREATMENT MORTALITY ADJUSTED FOR LOSS TO CARE BIASES

UNAIDS projections of pediatric HIV prevalence and deaths rely on the International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium for mortality estimates among children with HIV (CHIV) receiving antiretroviral therapy (ART). Previous estimates may no longer be accurate due to expanded pediatric HIV care and treatment, and the possibility of unreported deaths in CHIV considered…

MORTALITY IN CHILDREN & YOUTH (

Despite significant progress in addressing HIV/AIDS, children, adolescents and young adults living with HIV (CAYHIV) continue to have poorer outcomes than adults aged ?25 years. Loss to follow up (LTF) in antiretroviral therapy (ART) programs is a major challenge to achieving optimal treatment outcomes and the UNAIDS 2030 target. We aimed to compare site-reported mortality…

MICROBIOLOGICAL FEATURES AND FOLLOW-UP OF NEONATES BORN TO MOTHERS WITH COVID-19

Literature evaluating the effect of SARS-CoV-2 infection in exposed newborns during pregnancy is still scarce. Although a 3% rate of perinatal transmission has been described, there is not enough evidence of viral transmission in biological samples through microbiological techniques. Our aim is to describe perinatal transmission in newborns exposed to SARS-CoV-2 during pregnancy and their…

SAFETY AND EFFICACY OF REMDESIVIR IN A PEDIATRIC COVID-19 POPULATION

COVID-19 is generally a mild disease in children and infants. However, a small proportion develop severe disease requiring intensive care and ventilatory support. Remdesivir (RDV), a direct-acting nucleotide pro-drug inhibitor of viral RNA-dependent RNA polymerases, has been shown to shorten time to recovery in adults with severe COVID-19. The aim of this study is to…

SARS-CoV-2 VACCINES INDUCE DURABLE NEUTRALIZING ANTIBODIES IN INFANT RHESUS MACAQUES

SARS-CoV-2 vaccines have shown promising efficacy in human adult trials, but immunogenicity and efficacy studies in the pediatric population are lagging behind. Here we evaluated the immunogenicity of two prefusion stabilized Spike protein (S-2P) vaccine platforms in infant Rhesus Macaques (RM): an adjuvanted S-P2 subunit and mRNA vaccine. Infant RMs (2.5 months-old) were immunized intramuscularly…